PDF下载 ( 1317 KB)
Treatment strategies for alcoholic hepatitis
-
-
[1]中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中华肝脏病杂志, 2006, 14 (3) ∶164-166. [2]刘畅, 王颖, 王炳元, 等.88例酒精性肝炎的临床分析[J].药品评价, 2007, 4 (2) ∶110-113. [3]孟晓丹, 向国卿, 贺小虎, 等.肝硬化病因及临床特点分析178例[J].世界华人消化杂志, 2008, 16 (17) ∶1880-1884. [4]Sass DA, Shaikh OS.Alcoholic hepatitis[J].Clin Liver Dis, 2006, 10 (2) ∶219-37. [5]Forman LM, Lucey MR.Predicting the prognosis of chronic liver disease:an evolution from child to MELD.Mayo End-stage Liver Disease[J].Hepatology, 2001, 33 (2) ∶473-475. [6]Verma S, Ajudia K, Mendler M, et al.Prevalence of septic e-vents, type1hepatorenal syndrome, and mortality in severe alcohol-ic hepatitis and utility of discriminant function and MELD score in predicting these adverse events[J].Dig Dis Sci, 2006, 51 (9) ∶1637-1643. [7]Forrest EH, Evans CD, Stewart S, et al.Analysis of factors predic-tive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score[J].Gut, 2005, 54 (8) ∶1174-1179. [8]Mendenhall CL, Anderson S, Garcia-Pont P, et al.Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone[J].N Engl J Med, 1984, 311 (23) ∶1464-1470. [9]王炳元, 吴作艳, 曹艳雪, 等.慢性乙醇摄取对胃粘膜损害的实验研究[J].中国医科大学学报, 2003, 32 (1) ∶13-14. [10]王炳元.酒精戒断综合征的鉴别诊断与治疗 (附10例临床分析) [J].中国医科大学学报, 2000, 29 (1) ∶78-79. [11]Charlton M.Branched-chain amino acid enriched supplements as therapy for liver disease[J].J Nutr, 2006, 136 (Suppl1) ∶295S-298S. [12]Mendenhall CL, Moritz TE, Roselle GA, et al.Astudy of oral nu-tritional support with oxandrolone in malnourished patients with al-coholic hepatitis:results of a Department of Veterans Affairs cooper-ative study[J].Hepatology, 1993, 17 (4) ∶564-576. [13]WELLS R.Prednisolone and testosterone propionate in cirrhosis of the liver.A controlled trial[J].Lancet, 1960, 2 (7166) ∶1416-1419. [14]Morris JM, Forrest EH.Bilirubin response to corticosteroids in se-vere alcoholic hepatitis[J].Eur J Gastroenterol Hepatol, 2005, 17 (7) ∶759-762. [15]Christensen E, Gluud C.Glucocorticoids are ineffective in alcoholic hepatitis:a meta-analysis adjusting for confounding variables[J].Gut, 1995, 37 (1) ∶113-118. [16]Mathurin P, Abdelnour M, Ramond MJ, et al.Early change in bil-irubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone[J].Hepatology, 2003, 38 (6) ∶1363-1369. [17]Rambaldi A, Saconato HH, Christensen E, et al.Glucocorticoste-roids for alcoholic hepatitis[J].J Hepatology, 2008, 48 (Suppl2) ∶S347. [18]Dharancy S, Briand G, Louvet A, et al.Serum protein profiling of alcoholic hepatitis using mass spectrometry (seldi-tof ms protein-chip) :identification of a biomarker of response to corticosteroids[J].J Hepatology, 2008, 48 (Suppl2) ∶S15. [19]Stadlbauer V, Mookerjee RP, Wright GAK, et al.Increased neu-trophil toll-like-receptor2, 4and9expression in alcoholic hepa-titis is a result of its activation rather than its cause[J].J Hepatolo-gy, 2008, 48 (Suppl2) ∶S15. [20]Cabr E, Rodrguez-Iglesias P, Caballera J, et al.Short-and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition:a multicenter randomized trial[J].Hepatology, 2000, 32 (1) ∶36-42. [21]Nguyen-Khac E, Thevenot T, Piquet MA, et al.Treatment of se-vere acute alcoholic hepatitis (aah) with corticoids plus n-acetylcysteine (c-nac) versus corticoids (c) :planed interim analysis of a multicentre, controlled, randomized trial[J].J Hepatology, 2008, 48 (Suppl2) ∶S17. [22]Phillips M, Curtis H, Portmann B, et al.Antioxidants versus corti-costeroids in the treatment of severe alcoholic hepatitis-a random-ised clinical trial[J].J Hepatol, 2006, 44 (4) ∶784-90. [23]Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O.Pentoxifylline improves short-term survival in severe acute alcohol-ic hepatitis:a double-blind, placebo-controlled trial[J].Gas-troenterology, 2000, 119 (6) ∶1637-1642. [24]McAvoy NC, Forrest EH, Hayes PC.The glasgowalcoholic hepati-tis score and the effect of pentoxifylline in alcoholic hepatitis[J].Gut, 2005, 54 (Suppl2) ∶44A. [25]Watson E, Lafferty H, Forrest EH.When corticosteroids fail:res-cue treatment with pentoxifylline for alcoholic hepatitis[J].J Hepa-tology, 2008, 48 (Suppl2) ∶S366. [26]Boitard J, Louvet A, Bismuth B, S.et al.Tolerance and efficacy of the mars system in patients with severe alcoholic hepatitis non-responders to steroids:a pilot study[J].J Hepatology, 2008, 48 (Suppl2) ∶S355. [27]Rambaldi A, Gluud C.Anabolic-androgenic steroids for alcoholic liver disease[J].Cochrane Database Syst Rev, 2006, (4) ∶CD003045. [28]Lieber CS.Liver diseases by alcohol and hepatitis C:early detec-tion and new insights in pathogenesis lead to improved treatment[J].Am J Addict, 2001, 10 (Suppl) ∶29-50. [29]Lieber CS.New concepts of the pathogenesis of alcoholic liver dis-ease lead to novel treatments[J].Curr Gastroenterol Rep, 2004, 6 (1) ∶60-65. [30]Rambaldi A, Gluud C.S-adenosyl-L-methionine for alcoholic liver diseases[J].Cochrane Database Syst Rev, 2001, (4) ∶CD002235. [31]Mookerjee RP, Tilg H, Williams R, et al.Infliximab and alcoholic hepatitis[J].Hepatology, 2004, 40 (2) ∶499-500. [32]Dai WX, Zhang JD, Zhan SW, et al.Retrospective analysis of18cases of antithyroid drug (ATD) -induced agranulocytosis[J].En-docr J, 2002, 49 (1) ∶29-33. -
本文二维码
计量
- 文章访问数: 2158
- HTML全文浏览量: 6
- PDF下载量: 762
- 被引次数: 0
下载:
